Piramal Pharma Limited’s Piramal Critical Care (PCC) business, a producer of inhaled anesthetics and a global player in hospital generics, appointed Jeffrey Hampton president and chief operating officer. In his new role, Hampton will be based in the U.S. Peter DeYoung, CEO, Global Pharma, Piramal Pharma Ltd., said, “I welcome Jeff to Piramal Critical Care and wish him all the success in his new role. His experience across the domains of sales and marketing will help us develop stronger, long-...